glp 1 and autoimmune disease Glucagon-like peptide-1 receptor agonists in arthritis: current insights future directions GLP-1 Medications for Arthritis &
Description
It is produced in the alpha cells of the pancreas (insulin in the beta cells as I described earlier)
Degradation due to improper storage and absence of bioequivalence studies may result in unpredictable clinical outcomes
Patients should consult healthcare providers for personalized use, as these medications require monitoring for gastrointestinal (GI) effects, pancreatitis risk, and thyroid concerns
GLP-1: Glucagon-Like Peptide-1 An incretin hormone that stimulates insulin secretion, reduces glucagon release, slows gastric emptying, and Suppresses appetite, aiding weight loss
